Derriere to the future: is it time to rethink how we use antimicrobial agents?
Tillotson
G S
GS
Anti-Infective Scientific Relations, Bayer Corporation, West Haven, CT, USA. glenn.tillotson.b@bayer.com
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D011307:Drug Prescriptions / Q000592:standards*; D006801:Humans; D010406:Penicillins / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae
D000900:Anti-Bacterial Agents; D010406:Penicillins